Device manufacturer, as written on reports
Cardiac Pacemakers: medical device reports filed with FDA
44,368 reports name it as the manufacturer of the device involved, 1992–2022.
- 44,368
- reports naming it as manufacturer
- 0.2% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 60.4%
- classified as malfunction
- 62.3% across all reports
- 1.5%
- classified as death, as reported
- 0.9% across all reports
44,368 medical device reports received by FDA give Cardiac Pacemakers as the manufacturer of the device involved, 0.2% of the MAUDE database, from February 1992 to July 2022. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (60.4%), injury (38%) and death (1.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Contak Renewal 3 | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 2,564 | 0 | 5.7% |
| Endotak Reliance | Permanent defibrillator electrodes | 2,231 | 238 | 1.2% |
| Endotak Reliance G | Implantable cardioverter defibrillator (non-crt) | 2,074 | 1,049 | 0.6% |
| Flextend Is-1 Bi Positive Fix | Permanent pacemaker electrode | 1,890 | 0 | 1.2% |
| Contak Renewal | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 1,297 | 0 | 4.8% |
| Vitality Ds Vr | Implantable cardioverter defibrillator (non-crt) | 1,108 | 0 | 0.9% |
| Vitality Ds | Implantable cardioverter defibrillator (non-crt) | 1,089 | 0 | 1.1% |
| Vitality Avt | Implantable cardioverter defibrillator (non-crt) | 992 | 0 | 2.3% |
| Endotak Dsp | Implantable cardioverter defibrillator (non-crt) | 920 | 14 | 1.6% |
| Insignia Plus | Implantable pacemaker pulse-generator | 890 | 0 | 9.1% |
| Vitality Vr | Implantable cardioverter defibrillator (non-crt) | 810 | 0 | 0.2% |
| Contak Renewal 3 Rf | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 794 | 0 | 1.6% |
| Insignia Ultra | Implantable pacemaker pulse-generator | 771 | 0 | 5.4% |
| Vitality 2 Vr | Implantable cardioverter defibrillator (non-crt) | 759 | 0 | 0.9% |
| Vitality Avt Fast-Charge | Implantable cardioverter defibrillator (non-crt) | 706 | 0 | 4.4% |
| Contak Renewal 3 Rf He | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 665 | 0 | 1.8% |
| Endotak C | Implantable cardioverter defibrillator (non-crt) | 595 | 6 | 1.7% |
| Contak Renewal 4 | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 499 | 0 | 0.6% |
| Easytrak | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 354 | 0 | 1.5% |
| Insignia Entra | Implantable pacemaker pulse-generator | 341 | 0 | 10.2% |
| Endotak Endurance Rx | Permanent pacemaker electrode | 300 | 18 | 0.4% |
| Endotak Endurance Ez | Implantable cardioverter defibrillator (non-crt) | 294 | 28 | 1.6% |
| Easytrak 2 | Drug eluting permanent left ventricular (lv) pacemaker electrode | 290 | 18 | 0.8% |
| Sweet Tip Bipolar Lead | Implantable pacemaker pulse-generator | 254 | 0 | 0% |
| Ventak Av | Implantable cardioverter defibrillator (non-crt) | 251 | 0 | 1.9% |
| Ventak Prizm 2 Vr | Implantable cardioverter defibrillator (non-crt) | 234 | 0 | 6.1% |
| Ventak Prizm He Vr | Implantable cardioverter defibrillator (non-crt) | 234 | 0 | 1.9% |
| Endotak Down-Sized Plus | Implantable cardioverter defibrillator (non-crt) | 227 | 0 | 0.4% |
| Contak Renewal 2 | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 220 | 0 | 0.5% |
| Endotak C Transvenous Defibrillation Lead | Implantable cardioverter defibrillator (non-crt) | 207 | 0 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LWS | Implantable cardioverter defibrillator (non-crt) | 26,151 | 58.9% |
| DTB | Permanent pacemaker electrode | 8,343 | 18.8% |
| DXY | Implantable pacemaker pulse-generator | 5,245 | 11.8% |
| NIK | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 4,161 | 9.4% |
| LWP | Implantable pulse generator, pacemaker (non-crt) | 227 | 0.5% |
| NKE | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 122 | 0.3% |
| NVZ | Pulse generator, permanent, implantable | 33 | 0.1% |
| DTD | Pacemaker lead adaptor | 26 | 0.1% |
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 16 | 0% |
| DQX | Wire, guide, catheter | 11 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Cardiac Pacemakers reports
How many FDA device reports name Cardiac Pacemakers as manufacturer?
44,368 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Contak Renewal 3 (2,564), Endotak Reliance (2,231), Endotak Reliance G (2,074), Flextend Is-1 Bi Positive Fix (1,890) and Contak Renewal (1,297).
Which device types does it report on?
implantable cardioverter defibrillator (non-crt) (58.9%), permanent pacemaker electrode (18.8%), implantable pacemaker pulse-generator (11.8%) and defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) (9.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.